Reduced protein O-glycosylation in the nervous system of the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis
- PMID: 22521585
- DOI: 10.1016/j.neulet.2012.04.018
Reduced protein O-glycosylation in the nervous system of the mutant SOD1 transgenic mouse model of amyotrophic lateral sclerosis
Abstract
In the neurodegenerative disease amyotrophic lateral sclerosis (ALS), a number of proteins have been found to be hyperphosphorylated, including neurofilament proteins (NFs). In addition to protein phosphorylation, another important post-translational modification is O-glycosylation with β-N-acetylglucosamine residues (O-GlcNAc) and it has been found that O-GlcNAc can modify proteins competitively with protein phosphorylation, so that increased O-GlcNAc can reduce phosphorylation at specific sites. We evaluated a transgenic mouse model of ALS that overexpresses mutant superoxide dismutase (mSOD) and found that O-GlcNAc immunoreactivity levels are decreased in spinal cord tissue from mSOD mice, compared to controls. This reduction in O-GlcNAc levels is prominent in the motor neurons of spinal cord. We find that inhibition of O-GlcNAcase (OGA), the enzyme catalyzing removal of O-GlcNAc, using the inhibitor NButGT for 3 days, resulted in increased O-GlcNAc levels in spinal cord, both in mSOD and control mice. Furthermore, NButGT increased levels of O-GlcNAc modified NF-medium in spinal cords of control mice, but not in mSOD mice. These observations suggest that the neurodegeneration found in mSOD mice is associated with a reduction of O-GlcNAc levels in neurons, including motor neurons.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
O-glycosylation of the tail domain of neurofilament protein M in human neurons and in spinal cord tissue of a rat model of amyotrophic lateral sclerosis (ALS).J Biol Chem. 2005 Sep 9;280(36):31648-58. doi: 10.1074/jbc.M504395200. Epub 2005 Jul 8. J Biol Chem. 2005. PMID: 16006557
-
Increased phospho-adducin immunoreactivity in a murine model of amyotrophic lateral sclerosis.Neuroscience. 2005;134(3):833-46. doi: 10.1016/j.neuroscience.2005.04.036. Neuroscience. 2005. PMID: 15994023
-
Origin and distribution of bone marrow-derived cells in the central nervous system in a mouse model of amyotrophic lateral sclerosis.Glia. 2006 May;53(7):744-53. doi: 10.1002/glia.20331. Glia. 2006. PMID: 16518833
-
Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.Lab Invest. 1997 Apr;76(4):441-56. Lab Invest. 1997. PMID: 9111507 Review.
-
Defective neurofilament transport in mouse models of amyotrophic lateral sclerosis: a review.Neurochem Res. 2003 Jul;28(7):1041-7. doi: 10.1023/a:1023259207015. Neurochem Res. 2003. PMID: 12737529 Review.
Cited by
-
O-GlcNAcylation: key regulator of glycolytic pathways.J Bioenerg Biomembr. 2018 Jun;50(3):189-198. doi: 10.1007/s10863-018-9742-3. Epub 2018 Jan 18. J Bioenerg Biomembr. 2018. PMID: 29344764 Free PMC article. Review.
-
O-GlcNAcylation in ischemic diseases.Front Pharmacol. 2024 May 9;15:1377235. doi: 10.3389/fphar.2024.1377235. eCollection 2024. Front Pharmacol. 2024. PMID: 38783961 Free PMC article. Review.
-
Protein O-GlcNAcylation in Metabolic Modulation of Skeletal Muscle: A Bright but Long Way to Go.Metabolites. 2022 Sep 22;12(10):888. doi: 10.3390/metabo12100888. Metabolites. 2022. PMID: 36295790 Free PMC article. Review.
-
The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.Environ Sci Pollut Res Int. 2020 Apr;27(11):11461-11483. doi: 10.1007/s11356-020-07914-1. Epub 2020 Feb 19. Environ Sci Pollut Res Int. 2020. PMID: 32072427 Review.
-
Glycosylation and behavioral symptoms in neurological disorders.Transl Psychiatry. 2023 May 8;13(1):154. doi: 10.1038/s41398-023-02446-x. Transl Psychiatry. 2023. PMID: 37156804 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous